All news from Anaesthesiology

USFDA Approved the Use of L-glutamine to Treat Sickle Cell Disease

According to a new study reported in The Lancet Haematology, the USFDA approved the use of L-glutamine for the treatment of patients aged 5 years and older with sickle cell disease, on the basis of the results of a randomised phase 3 clinical trial. The trial demonstrated that patients treated with L-glutamine for 48 weeks had reduced frequency and length of hospital visits for sickle cell pain crisis compared with patients treated with placebo.

To Assess the Feasibility and Acceptability of CHWs in Ear

In this study, researchers estimated that hearing loss is the most common sensory disability and its prevalence is increasing globally with population ageing.  They had estimated 360 million people, or 5.3% of the world’s population, are living with disabling hearing impairment.  The leading causes of hearing impairment in sub-Saharan Africa are believed to be middle ear disease and impacted wax, and are therefore easily amenable to treatment and prevention.

Noise May Disrupt the Body and Harm to Cardiovascular System

According to a new study, researchers have examined that noise may disrupt the body on the cellular level in a way that increases the risk of common heart disease risk factors. An underlying mechanism that may lead to noise-induced heart disease. The review is in response to growing evidence connecting environmental noise, including from road traffic and aircrafts, to the development of heart disease, such as coronary artery disease, arterial hypertension, stroke and heart failure. The study is published in the Journal of the American College of Cardiology.